The ‘peptoid’ approach to the design of non-peptide, small molecule agonists and antagonists of neuropeptides
- 30 April 1995
- journal article
- review article
- Published by Elsevier in Trends in Biotechnology
- Vol. 13 (4), 132-134
- https://doi.org/10.1016/s0167-7799(00)88923-4
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease InhibitorsScience, 1994
- De novo design and synthesis of somatostatin non-peptide peptidomimetics utilizing .beta.-D-glucose as a novel scaffoldingJournal of the American Chemical Society, 1993
- Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonistNature, 1993
- Direct design of a potent non-peptide fibrinogen receptor antagonist based on the structure and conformation of a highly constrained cyclic RGD peptideJournal of the American Chemical Society, 1993
- Peptidomimetics for Receptor Ligands—Discovery, Development, and Medical PerspectivesAngewandte Chemie International Edition in English, 1993
- A Nonpeptidyl Growth Hormone SecretagogueScience, 1993
- Peptoids—A New Approach to the Development of PharmaceuticalsAngewandte Chemie International Edition in English, 1993
- The first design and synthesis of a steroidal peptidomimetic. The potential value of peptidomimetics in elucidating the bioactive conformation of peptide ligandsJournal of the American Chemical Society, 1992
- Medicinal Chemistry in the Golden Age of Biology: Lessons from Steroid and Peptide ResearchAngewandte Chemie International Edition in English, 1991
- Speculations on the design of nonpeptidic peptidomimeticsTrends in Pharmacological Sciences, 1982